DK1877409T3 - Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf - Google Patents

Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf

Info

Publication number
DK1877409T3
DK1877409T3 DK06743743T DK06743743T DK1877409T3 DK 1877409 T3 DK1877409 T3 DK 1877409T3 DK 06743743 T DK06743743 T DK 06743743T DK 06743743 T DK06743743 T DK 06743743T DK 1877409 T3 DK1877409 T3 DK 1877409T3
Authority
DK
Denmark
Prior art keywords
preparation
same
compositions containing
substituted pyrrolopyridines
pyrrolopyridines
Prior art date
Application number
DK06743743T
Other languages
Danish (da)
English (en)
Inventor
Michel Tabart
Eric Bacque
Frank Halley
Pascal Desmazeau
Fabrice Viviani
Catherine Souaille
Baptiste Ronan
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1877409T3 publication Critical patent/DK1877409T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK06743743T 2005-04-26 2006-04-26 Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf DK1877409T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504173A FR2884821B1 (fr) 2005-04-26 2005-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2006/000925 WO2006114520A2 (fr) 2005-04-26 2006-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
DK1877409T3 true DK1877409T3 (da) 2009-10-05

Family

ID=35517344

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06743743T DK1877409T3 (da) 2005-04-26 2006-04-26 Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf

Country Status (33)

Country Link
US (1) US7947706B2 (pl)
EP (1) EP1877409B1 (pl)
JP (1) JP2008539211A (pl)
KR (1) KR20080007229A (pl)
CN (1) CN101166739A (pl)
AR (1) AR061386A1 (pl)
AT (1) ATE433976T1 (pl)
AU (1) AU2006239105A1 (pl)
BR (1) BRPI0613161A2 (pl)
CA (1) CA2605744A1 (pl)
CR (1) CR9463A (pl)
CY (1) CY1109369T1 (pl)
DE (1) DE602006007337D1 (pl)
DK (1) DK1877409T3 (pl)
DO (1) DOP2006000096A (pl)
EA (1) EA012983B1 (pl)
ES (1) ES2328629T3 (pl)
FR (1) FR2884821B1 (pl)
GT (1) GT200600174A (pl)
HR (1) HRP20090494T1 (pl)
IL (1) IL186523A0 (pl)
MA (1) MA29480B1 (pl)
MX (1) MX2007013084A (pl)
NO (1) NO20075918L (pl)
PA (1) PA8671301A1 (pl)
PE (1) PE20071420A1 (pl)
PL (1) PL1877409T3 (pl)
PT (1) PT1877409E (pl)
RS (1) RS51136B (pl)
SI (1) SI1877409T1 (pl)
TN (1) TNSN07360A1 (pl)
TW (1) TW200718701A (pl)
WO (1) WO2006114520A2 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
SG175609A1 (en) 2006-10-09 2011-11-28 Takeda Pharmaceutical Kinase inhibitors
EP2223925A1 (en) * 2006-10-09 2010-09-01 Takeda Pharmaceutical Company Limited Kinase inhibitors
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
EP2114941B1 (en) * 2006-12-22 2015-03-25 Astex Therapeutics Limited Bicyclic heterocyclic compounds as fgfr inhibitors
AU2007337895C1 (en) 2006-12-22 2014-07-31 Astex Therapeutics Limited Tricyclic amine derivatives as protein tyrosine kinase inhibitors
US20100190777A1 (en) 2007-07-17 2010-07-29 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
DE102008052943A1 (de) 2008-10-23 2010-04-29 Merck Patent Gmbh Azaindolderivate
CN105237530A (zh) 2009-04-03 2016-01-13 豪夫迈罗氏公司 丙烷-1-磺酸{3-[5-(4-氯-苯基)-1H-吡咯并[2,3-b]吡啶-3-羰基]-2,4-二氟-苯基}-酰胺组合物及其用途
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
US20110030037A1 (en) * 2009-07-07 2011-02-03 Vadim Olshansky Zone migration in network access
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
WO2011057022A1 (en) 2009-11-06 2011-05-12 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
PT2672967T (pt) 2011-02-07 2018-12-07 Plexxikon Inc Compostos e métodos de modulação da quinase e suas indicações
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
WO2013181075A1 (en) * 2012-05-29 2013-12-05 Merck Sharp & Dohme Corp. Isotopically labeled biaryl urea compounds
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US20140275082A1 (en) * 2013-03-14 2014-09-18 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
GB201310460D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds
GB201310464D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3254843B2 (ja) * 1993-08-09 2002-02-12 三菱ウェルファーマ株式会社 新規縮合ヘテロ環誘導体
US6335342B1 (en) * 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
GB0115109D0 (en) * 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
JP2005508904A (ja) * 2001-09-11 2005-04-07 スミスクライン ビーチャム コーポレーション 血管新生阻害剤としてのフロ−及びチエノピリミジン誘導体
WO2003028724A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
US7129225B2 (en) * 2001-10-22 2006-10-31 The Research Foundation Of State University Of New York Protection against and treatment of hearing loss
CA2480317A1 (en) * 2002-03-28 2003-10-09 Eisai Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
FR2878849B1 (fr) 2004-12-06 2008-09-12 Aventis Pharma Sa Indoles substitues, compositions les contenant, procede de fabrication et utilisation

Also Published As

Publication number Publication date
WO2006114520A3 (fr) 2007-03-01
HRP20090494T1 (hr) 2009-10-31
WO2006114520A2 (fr) 2006-11-02
EP1877409A2 (fr) 2008-01-16
TW200718701A (en) 2007-05-16
ES2328629T3 (es) 2009-11-16
PE20071420A1 (es) 2007-01-20
RS51136B (sr) 2010-10-31
US20080139606A1 (en) 2008-06-12
DOP2006000096A (es) 2007-04-15
PT1877409E (pt) 2009-09-16
EA200702329A1 (ru) 2008-02-28
SI1877409T1 (sl) 2009-12-31
ATE433976T1 (de) 2009-07-15
EP1877409B1 (fr) 2009-06-17
JP2008539211A (ja) 2008-11-13
KR20080007229A (ko) 2008-01-17
PL1877409T3 (pl) 2009-12-31
AR061386A1 (es) 2008-08-27
US7947706B2 (en) 2011-05-24
FR2884821A1 (fr) 2006-10-27
CN101166739A (zh) 2008-04-23
AU2006239105A1 (en) 2006-11-02
DE602006007337D1 (de) 2009-07-30
CA2605744A1 (fr) 2006-11-02
FR2884821B1 (fr) 2007-07-06
MA29480B1 (fr) 2008-05-02
GT200600174A (es) 2006-12-26
CY1109369T1 (el) 2014-07-02
NO20075918L (no) 2007-11-19
IL186523A0 (en) 2008-01-20
CR9463A (es) 2008-02-21
TNSN07360A1 (en) 2008-12-31
EA012983B1 (ru) 2010-02-26
PA8671301A1 (es) 2006-12-07
BRPI0613161A2 (pt) 2010-12-21
MX2007013084A (es) 2008-01-11

Similar Documents

Publication Publication Date Title
DK1877409T3 (da) Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf
ZA200709856B (en) Fluorene derivatives,compositions containing said derivatives and the use thereof
IL184524A0 (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
IL198509A0 (en) Azaindole derivatives, compositions containing the same and uses thereof
IL188050A (en) The history of azaindazole, their medicinal preparations and their uses
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
ZA200801773B (en) New formulation
SI1888580T1 (sl) Pirido d pirimidini uporabni kot inhibitorjiHCV in postopki za njihovo pripravo
DK2076260T3 (da) N-methylaminomethyl-isoindol-forbindelser og sammensætninger, der indeholder disse, samt fremgangsmåder til deres anvendelse
TWI370115B (en) New formulation
IL190423A0 (en) Selected cgrp antagonists , methods for the production thereof and their use as medicaments
IL184111A0 (en) Prostaglandin-containing compositions and methods for enhancing the stability thereof
NO20082249L (no) Fusert heterocyklisk derivat, medisinsk sammensetning inneholdende samme samt medisinsk bruk derav
DK1910288T3 (da) 3-aminocarbazolsammensætninger, farmaceutiske sammensætninger, der indeholder disse, samt fremgangsmåde til deres fremstilling
IL188861A0 (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL189497A0 (en) Selected cgrp antagonists, methods for the production thereof and their use as medicaments
EP1845099A4 (en) ARTIFICIAL DERIVATIVES (QINGHAOSU), SYNTHESIS METHODS AND APPLICATIONS, AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME DERIVATIVES
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
EP1900374A4 (en) ANGIOGENETIC AGENT CONTAINING ADRENOMEDULIN AS ACTIVE INGREDIENT
DE502006004524D1 (de) Verfahren zur herstellung von 3,7-diaza-bicycloä3.3.1ünonan-verbindungen
FI20055133A (fi) Iskulaite
IL190063A (en) The history of cycloalkanes is preserved, their medicinal preparations and their uses